Skip to main content
Contact Us
Subscribe
E-Edition
64°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Avita Medical Inc
(NQ:
RCEL
)
8.260
-0.450 (-5.17%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Avita Medical Inc
< Previous
1
2
3
4
5
Next >
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
January 18, 2023
We're starting the day with a breakdown of the biggest pre-market stock movers traders will want to watch on Wednesday morning!
Via
InvestorPlace
Moderna, Tesla And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session
January 18, 2023
U.S. stock futures traded mixed this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
AVITA Medical Submits FDA PMA Application to Expand Indication to Vitiligo
December 19, 2022
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical: Q4 Earnings Insights
August 11, 2022
AVITA Medical (NASDAQ:RCEL) reported its Q4 earnings results on Thursday, August 11, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Earnings Scheduled For August 11, 2022
August 11, 2022
Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
April 26, 2022
During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low.
Via
Benzinga
AVITA Medical Announces Results of 2022 Annual Meeting of Stockholders
December 12, 2022
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical Submits FDA PMA Supplement to Further Expand Indication to Soft Tissue Repair
December 12, 2022
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical® to Present at the Piper Sandler 34th Annual Healthcare Conference
November 21, 2022
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical® to Host Investor Webinar Briefing
November 16, 2022
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical Reports Third Quarter 2022 Financial Results
November 10, 2022
From
AVITA Medical
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 10, 2022
Gainers NexImmune (NASDAQ:NEXI) shares rose 38.8% to $0.7 during Thursday's pre-market session. The market value of their outstanding shares is at $16.9 million.
Via
Benzinga
AVITA Medical Announces Achievement of Co-Primary Endpoints in Updated Analysis of Pivotal Trial of RECELL® System for Soft Tissue Repair
November 09, 2022
From
AVITA Medical
Via
GlobeNewswire
Earnings Scheduled For November 10, 2022
November 10, 2022
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report earnings for its third quarter.
Via
Benzinga
AVITA Medical Announces FDA Breakthrough Device Designations for the RECELL® System
November 03, 2022
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical to Announce Third Quarter 2022 Financial Results
October 20, 2022
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical Appoints Industry Leader James Corbett as Chief Executive Officer
September 28, 2022
From
AVITA Medical
Via
GlobeNewswire
Investor Webinar Briefing (RCEL, AVH)
September 19, 2022
Valencia, California and Melbourne, Australia--(Newsfile Corp. - September 19, 2022) - AVITA Medical, Inc. (NASDAQ: RCEL) (ASX: AVH), a regenerative...
Via
Newsfile
Important Biotech Catalysts For September 12, 2022 - End Of The Day Summary
September 12, 2022
Via
Benzinga
AVITA Shares Climb Following Positive Results From RECELL System Study In Stable Vitiligo Lesions
September 12, 2022
AVITA Medical (NASDAQ: RCEL) reveals positive top-line results from a pivotal trial evaluating the safety and effectiveness of the RECELL System for repigmentation of stable vitiligo lesions.
Via
Benzinga
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
August 11, 2022
Via
Benzinga
AVITA Medical Shares Climb On Topline Results From Soft Tissue Reconstruction Study, Sees PMA Submission By Year-end
August 11, 2022
AVITA Medical (NASDAQ: RCEL) announced topline results from its pivotal trial evaluating the safety and effectiveness of the RECELL System combined with meshed autograft for reduction of donor skin...
Via
Benzinga
AVITA Medical: Q3 Earnings Insights
May 12, 2022
AVITA Medical (NASDAQ:RCEL) reported its Q3 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings AVITA Medical beat estimated...
Via
Benzinga
Earnings Scheduled For May 12, 2022
May 12, 2022
Companies Reporting Before The Bell • Chicago Atlantic Real (NASDAQ:REFI) is projected to report earnings for its first quarter.
Via
Benzinga
AVITA Medical Modifies BARDA Contract For RECELL System In Soft Tissue Reconstruction
March 22, 2022
Biomedical Advanced Research and Development Authority (BARDA) has
Via
Benzinga
AVITA Medical Inks Supply Pact With Premier For RECELL System
March 03, 2022
AVITA Medical Inc (NASDAQ: RCEL) has been awarded a group purchasing agreement with Premier Inc (NASDAQ: PINC) The new agreement allows Premier members,...
Via
Benzinga
The Daily Biotech Pulse: NuCana Shelves Biliary Tract Cancer Study, Tricida Data Readout Pushed Back Due to Ukrainian Crisis, Synlogic Names New CFO
March 03, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus NuCana Discontinues Biliary Tract Cancer Study Following Futility Analysis...
Via
Benzinga
44 Stocks Moving In Tuesday's Mid-Day Session
March 01, 2022
Gainers Avenue Therapeutics, Inc. (NASDAQ: ATXI) climbed 193% to $0.9962 after jumping 36% on Monday. GBS Inc. (NASDAQ: GBS) rose 73.3% to $0.7971 after declining around 9% on...
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
March 15, 2022
During Tuesday's session, 454 stocks hit new 52-week lows. Intriguing Points From Today's 52-Week Lows: Taiwan Semiconductor (NYSE:TSM) was the largest company by...
Via
Benzinga
80 Biggest Movers From Yesterday
March 02, 2022
Gainers Avenue Therapeutics, Inc. (NASDAQ: ATXI) jumped 78.5% to close at $0.6066 on Tuesday after jumping 36% on Monday. CTI BioPharma Corp. (NASDAQ: CTIC) surged 63...
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.